Patent Assignment
Reel/Frame 035505/0696
Release of Security Interest
Recorded: 2015-04-27
Pages: 7
Assignor
MORGAN STANLEY SENIOR FUNDING, INC.
Executed: 2015-04-22
Assignee
DARAVITA LIMITED (F/K/A ALKERMES SCIENCE ONE LIMITED, SUCCESSOR IN INTEREST TO ALKERMES PHARMA IRELAND LIMITED)
CONNAUGHT HOUSE, 1 BURLINGTON ROAD, DUBLIN 4, IRELAND
Covered Properties
(17)
Reduction of Intravenously Administered Nanoparticulate-Formulation- Induced Adverse Physiological Reactions
Patent:
5,834,025 →
Application:
08/696,754 →
Multiparticulate modified release composition
Patent:
6,228,398 →
Application:
09/566,636 →
Multiparticulate Modified Release Composition
Compositions Having a Combination of Immediate Release and Controlled Release Characteristics
Multiparticulate Modified Release Composition
Multiparticulate Modified Release Composition
Nanoparticulate Compositions Having Lysozyme as a Surface Stabilizer
Nanoparticulate meloxicam formulations
Multiparticulate modified release composition
Application:
10/827,689 →
Publication:
US 2004/0197405
Multiparticulate modified release composition
Application:
11/372,857 →
Publication:
US 2006/0240105
Reduction of Intravenously Administered Nanoparticulate-Formulation-Induced Adverse Physiological Reactions
Patent:
41,884 →
Application:
12/027,100 →
Nanoparticulate Compositions Having Lysozyme as a Surface Stabilizer
Controlled Release Compositions Comprising a Combination of Isosorbide Dinitrate and Hydralazine Hydrochloride
Method of Treatment Using Nanoparticulate Compositions Having Lysozyme as a Surface Stabilizer
Nanoparticulate Meloxicam Formulations
Application:
13/941,076 →
Publication:
US 2014/0141083
Method of Treatment Using Nanoparticulate Compositions Having Lysozyme as a Surface Stabilizer
Application:
14/182,097 →
Publication:
US 2014/0234225
Controlled Release Compositions Comprising a Combination of Isosorbide Dinitrate and Hydralazine Hydrochloride
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Patent Security Agreement (First Lien)
Sep 29, 2011
From: ALKERMES, INC.; ALKERMES PHARMA IRELAND LIMITED; ALKERMES CONTROLLED THERAPEUTICS INC.
To: MORGAN STANLEY SENIOR FUNDING, INC.
Reel/Frame 026994/0186 →
Patent Security Agreement (Second Lien)
Sep 29, 2011
From: ALKERMES, INC.; ALKERMES PHARMA IRELAND LIMITED; ALKERMES CONTROLLED THERAPEUTICS INC.
To: MORGAN STANLEY SENIOR FUNDING, INC.
Reel/Frame 026994/0245 →
Assignment of Assignor's Interest
Jul 27, 2012
From: REKHI, GURVINDER SINGH
To: ELAN CORPORATION, PLC
Reel/Frame 028657/0726 →
Asset Transfer Agreement
Jul 27, 2012
From: ELAN PHARMA INTERNATIONAL LIMITED
To: EDT PHARMA HOLDINGS LIMITED
Reel/Frame 028653/0835 →
Notice of Change in Registered Office Address
Jul 27, 2012
From: ALKERMES PHARMA IRELAND LIMITED
To: ALKERMES PHARMA IRELAND LIMITED
Reel/Frame 028653/0997 →
Change of Name
Jul 27, 2012
From: EDT PHARMA HOLDINGS LIMITED
To: ALKERMES PHARMA IRELAND LIMITED
Reel/Frame 028656/0245 →
Notice of Change in Registered Office Address
Sep 5, 2012
From: EDT PHARMA HOLDINGS
To: EDT PHARMA HOLDINGS
Reel/Frame 028914/0036 →
Change of Name
Sep 5, 2012
From: EDT PHARMA HOLDINGS LIMITED
To: ALKERMES PHARMA IRELAND LIMITED
Reel/Frame 028914/0039 →
Asset Transfer Agreement
Sep 5, 2012
From: ELAN PHARMA INTERNATIONAL LIMITED
To: EDT PHARMA HOLDINGS LIMITED
Reel/Frame 028914/0018 →
Notice of Change in Registered Office Address
Sep 5, 2012
From: ALKERMES PHARMA IRELAND LIMITED
To: ALKERMES PHARMA IRELAND LIMITED
Reel/Frame 028914/0106 →
Asset Transfer Agreement
Oct 2, 2012
From: ELAN PHARMA INTERNATIONAL LIMITED
To: EDT PHARMA HOLDINGS LIMITED
Reel/Frame 029066/0655 →
Change of Name
Oct 2, 2012
From: EDT PHARMA HOLDINGS LIMITED
To: ALKERMES PHARMA IRELAND LIMITED
Reel/Frame 029064/0645 →
Asset Transfer Agreement
Oct 10, 2012
From: ELAN PHARMA INTERNATIONAL LIMITED
To: EDT PHARMA HOLDINGS LIMITED
Reel/Frame 029108/0426 →
Change of Name
Oct 10, 2012
From: EDT PHARMA HOLDINGS LIMITED
To: ALKERMES PHARMA IRELAND LIMITED
Reel/Frame 029104/0071 →
Change of Name
Oct 10, 2012
From: EDT PHARMA HOLDINGS LIMITED
To: ALKERMES PHARMA IRELAND LIMITED
Reel/Frame 029103/0695 →
Assignment of Assignor's Interest
Oct 10, 2012
From: ELAN PHARMA INTERNATIONAL LIMITED
To: EDT PHARMA HOLDINGS LIMITED
Reel/Frame 029103/0465 →
Release by Secured Party (Second Lien)
Oct 12, 2012
From: MORGAN STANLEY SENIOR FUNDING, INC.
To: ALKERMES, INC.; ALKERMES PHARMA IRELAND LIMITED; ALKERMES CONTROLLED THERAPEUTICS INC.
Reel/Frame 029116/0379 →
Asset Transfer Agreement
Apr 12, 2014
From: ELAN PHARMA INTERNATIONAL LIMITED
To: EDT PHARMA HOLDINGS LIMITED
Reel/Frame 032672/0001 →
Change of Name
Apr 12, 2014
From: EDT PHARMA HOLDINGS LIMITED
To: ALKERMES PHARMA IRELAND LIMITED
Reel/Frame 032661/0663 →
Intellectual Property Transfer and License Agreement
Aug 1, 2014
From: ALKERMES PHARMA IRELAND LIMITED
To: ALKERMES SCIENCE ONE LIMITED
Reel/Frame 033460/0156 →
Property Transfer Agreement
Aug 6, 2014
From: ALKERMES PHARMA IRELAND LIMITED
To: ALKERMES SCIENCE ONE LIMITED
Reel/Frame 033483/0891 →
Second Amendment to Intellectual Property Transfer and License Agreement
Aug 8, 2014
From: ALKERMES PHARMA IRELAND LIMITED
To: ALKERMES SCIENCE ONE LIMITED
Reel/Frame 033500/0707 →
Property Transfer Agreement
Aug 12, 2014
From: ALKERMES PHARMA IRELAND LIMITED
To: ALKERMES SCIENCE ONE LIMITED
Reel/Frame 033522/0048 →
Transfer Agreement
Mar 26, 2015
From: ALKERMES PHARMA IRELAND LIMITED
To: ALKERMES SCIENCE ONE LIMITED
Reel/Frame 035295/0945 →
Change of Name
Mar 26, 2015
From: ALKERMES SCIENCE ONE LIMITED
To: DARAVITA LIMITED
Reel/Frame 035264/0078 →